| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
A molecular signature of metastasis in primary solid tumors
Ramaswamy S, Ross KN, Lander ES, Golub TR NATURE GENETICS 33 (1): 49-54 JAN 2003 and the citing papers |
Nodes: 212,
Authors: 1098,
Journals: 111,
Outer References: 8910,
Words: 854
Collection span: 2003 - 2005
View: Overview. Sorted by NCR.
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 3 | 255 | 116 2004 ENDOCRINE-RELATED CANCER 11(3):497-522 Lacroix M; Toillon RA; Leclercq G Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics | 0 | 0 |
| 2 | 2 | 253 | 180 2004 ONCOGENE 23(18):3248-3264 Rajasekhar VK; Holland EC Postgenomic global analysis of translational control induced by oncogenic signaling | 0 | 3 |
| 3 | 1 | 236 | 144 2004 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 130(9):497-513 Qin LX; Tang ZY Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature | 0 | 0 |
| 4 | 1 | 219 | 53 2003 PATHOLOGY & ONCOLOGY RESEARCH 9(1):49-72 Timar J; Ladanyi A; Petak I; Jeney A; Kopper L Molecular pathology of tumor metastasis III - Target array and combinatorial therapies | 0 | 2 |
| 5 | 2 | 201 | 9 2003 CANCER LETTERS 198(1):1-20 Shevde LA; Welch DR Metastasis suppressor pathways - an evolving paradigm | 4 | 8 |
| 6 | 1 | 198 | 27 2003 IMMUNOLOGICAL REVIEWS 194(1):140-163 Shaughnessy JD; Barlogie B Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling | 0 | 8 |
| 7 | 1 | 198 | 103 2004 CELLULAR SIGNALLING 16(10):1085-1104 Zimber A; Nguyen QD; Gespach C Nuclear bodies and compartments: Functional roles and cellular signalling in health and disease | 0 | 2 |
| 8 | 1 | 175 | 115 2004 CURRENT PHARMACEUTICAL DESIGN 10(31):3913-3928 Desnoyers L Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates | 0 | 1 |
| 9 | 1 | 167 | 187 2004 ORAL ONCOLOGY 40(7):656-667 Takes RP Staging of the neck in patients with head and neck squamous cell cancer: Imaging techniques and biomarkers | 0 | 0 |
| 10 | 1 | 162 | 47 2003 NATURE GENETICS 34(4):369-376 Albertson DG; Collins C; McCormick F; Gray JW Chromosome aberrations in solid tumors | 5 | 31 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 1 | 154 | 32 2003 JOURNAL OF CLINICAL INVESTIGATION 112(12):1776-1784 Kalluri R; Neilson EG Epithelial-mesenchymal transition and its implications for fibrosis | 0 | 19 |
| 12 | 1 | 150 | 31 2003 JOURNAL OF CLINICAL INVESTIGATION 112(11):1603-1618 Melmed S Mechanisms for pituitary tumorigenesis: the plastic pituitary | 0 | 4 |
| 13 | 2 | 142 | 52 2003 ONCOGENE 22(42):6524-6536 Bogenrieder T; Herlyn M Axis of evil: molecular mechanisms of cancer metastasis | 1 | 29 |
| 14 | 1 | 140 | 195 2004 SEMINARS IN ONCOLOGY 31(1):4-19 Meyerson M; Franklin WA; Kelley MJ Molecular classification and molecular genetics of human lung cancers | 1 | 4 |
| 15 | 3 | 135 | 179 2004 ONCOGENE 23(18):3189-3199 De Benedetti A; Graff JR eIF-4E expression and its role in malignancies and metastases | 0 | 7 |
| 16 | 1 | 134 | 1 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89:35-67 Klein CA The systemic progression of human cancer: A focus on the individual disseminated cancer cell - The unit of selection | 1 | 2 |
| 17 | 1 | 131 | 113 2004 CURRENT DRUG TARGETS 5(4):333-346 Stein WD; Bates SE; Fojo T Intractable cancers: The many faces of multidrug resistance and the many targets it presents for therapeutic attack | 0 | 0 |
| 18 | 1 | 124 | 17 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(3):384-395 Xiang ZY; Yang YN; Ma XJ; Ding W Microarray expression profiling: Analysis and applications | 1 | 8 |
| 19 | 2 | 124 | 111 2004 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 7(3):183-206 Kim AS Clinical impact of gene expression profiling on oncology diagnosis, prognosis, and treatment | 0 | 1 |
| 20 | 2 | 113 | 119 2004 EUROPEAN JOURNAL OF CANCER 40(17):2623-2632 Wulfkuhle J; Espina V; Liotta L; Petricoin E Genomic and proteomic technologies for individualisation and improvement of cancer treatment | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 1 | 111 | 124 2004 FRONTIERS IN BIOSCIENCE 9:1023-1034 Vincan E Frizzled/WNT signalling: The insidious promoter of tumour growth and progression | 0 | 1 |
| 22 | 1 | 110 | 15 2003 CLINICAL & EXPERIMENTAL METASTASIS 20(3):265-273 Graff JR; Zimmer SG Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs | 3 | 19 |
| 23 | 7 | 108 | 121 2004 EXPERT OPINION ON THERAPEUTIC TARGETS 8(6):527-536 Hedley BD; Winquist E; Chambers AF Therapeutic targets for antimetastatic therapy | 0 | 0 |
| 24 | 1 | 107 | 176 2004 NATURE REVIEWS GENETICS 5(5):335-344 Shendure J; Mitra RD; Varma C; Church GM Advanced sequencing technologies: Methods and goals | 0 | 7 |
| 25 | 1 | 105 | 36 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(1):75-89 Fackler MJ; Evron E; Khan SA; Sukumar S Novel agents for chemoprevention, screening methods, and sampling issues | 0 | 1 |
| 26 | 1 | 103 | 23 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(4):431-442 Goessl C Diagnostic potential of circulating nucleic acids for oncology | 0 | 0 |
| 27 | 1 | 101 | 49 2003 NATURE REVIEWS CANCER 3(6):434-443 Perez-Losada J; Balmain A Stem-cell hierarchy in skin cancer | 0 | 31 |
| 28 | 1 | 100 | 151 2004 JOURNAL OF CLINICAL ONCOLOGY 22(17):3608-3617 Lin NU; Bellon JR; Winer EP CNS metastases in breast cancer | 0 | 0 |
| 29 | 1 | 97 | 169 2004 NATURE 429(6990):469-474 Strausberg RL; Simpson AJG; Old LJ; Riggins GJ Oncogenomics and the development of new cancer therapies | 0 | 0 |
| 30 | 1 | 94 | 29 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(3):213-225 Shaughnessy JD Global gene expression profiling in the study of multiple myeloma | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 2 | 93 | 129 2004 GENOME RESEARCH 14(6):1085-1094 Lee HK; Hsu AK; Sajdak J; Qin J; Pavlidis P Coexpression analysis of human genes across many microarray data sets | 0 | 0 |
| 32 | 1 | 93 | 165 2004 LUNG CANCER 46(2):135-148 Rosell R; Felip E; Garcia-Campelo R; Balana C The biology of non-small-cell lung cancer: identifying new targets for rational therapy | 0 | 0 |
| 33 | 1 | 92 | 167 2004 MOLECULAR AND CELLULAR BIOLOGY 24(22):9705-9725 Cao XH; Liu W; Lin F; Li H; Kolluri SK; et al. Retinoid X receptor regulates Nur77/thyroid hormone receptor 3-dependent apoptosis by modulating its nuclear export and mitochondrial targeting | 0 | 1 |
| 34 | 5 | 91 | 79 2004 CANCER CELL 6(1):17-32 Allinen M; Beroukhim R; Cai L; Brennan C; Lahti-Domenici J; et al. Molecular characterization of the tumor microenvironment in breast cancer | 0 | 7 |
| 35 | 2 | 90 | 37 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):257-268 Jacobsen BM; Richer JK; Sartorius CA; Horwitz KB Expression profiling of human breast cancers and gene regulation by progesterone receptors | 0 | 0 |
| 36 | 1 | 90 | 38 2003 JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA 8(3):321-334 Fargiano AA; Desai KV; Green JE Interrogating mouse mammary cancer models: Insights from gene expression profiling | 0 | 0 |
| 37 | 1 | 86 | 24 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(5):635-647 Dyrskjot L Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics | 0 | 3 |
| 38 | 1 | 86 | 26 2003 GENETICS 165(3):997-1015 Breitkreutz A; Boucher L; Breitkreutz BJ; Sultan M; Jurisica I; et al. Phenotypic and transcriptional plasticity directed by a yeast mitogen-activated protein kinase network | 0 | 4 |
| 39 | 1 | 83 | 120 2004 EXPERIMENTAL DERMATOLOGY 13(10):593-606 Kunz M; Ibrahim SM; Koczan D; Scheid S; Thiesen HJ; et al. DNA microarray technology and its applications in dermatology | 0 | 0 |
| 40 | 4 | 82 | 136 2004 INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY 48(5-6):573-581 Crnic I; Christofori G Novel technologies and recent advances in metastasis research | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 1 | 80 | 8 2003 CANCER CELL 4(3):209-221 Wang SY; Gao J; Lei QY; Rozengurt N; Pritchard C; et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer | 1 | 24 |
| 42 | 1 | 80 | 118 2004 EUROPEAN JOURNAL OF BIOCHEMISTRY 271(11):2189-2203 Joshi B; Cameron A; Jagus R Characterization of mammalian eIF4E-family members | 0 | 2 |
| 43 | 1 | 79 | 2 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89:157-181 Takahashi M; Sugimura J; Yang XM; Vogelzang N; Teh BS; et al. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics | 0 | 5 |
| 44 | 1 | 78 | 50 2003 NATURE REVIEWS CANCER 3(12):903-911 di Magliano MP; Hebrok M Hedgehog signalling in cancer formation and maintenance | 0 | 12 |
| 45 | 1 | 76 | 22 2003 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 3(3):375-385 Dobrin SE; Stephan DA Integrating microarrays into disease-gene identification strategies | 0 | 3 |
| 46 | 1 | 74 | 153 2004 JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY 23(1):13-31 Shioda T Application of DNA microarray to toxicological research | 0 | 1 |
| 47 | 1 | 73 | 4 2003 BREAST CANCER RESEARCH 5(6):320-328 Jeffrey SS; Pollack JR The diagnosis and management of pre-invasive breast disease - Promise of new technologies in understanding pre-invasive breast lesions | 0 | 4 |
| 48 | 2 | 73 | 158 2004 JOURNAL OF MEDICAL GENETICS 41(1):1-5 Foulkes WD BRCA1 functions as a breast stem cell regulator | 1 | 5 |
| 49 | 2 | 73 | 209 2005 JOURNAL OF UROLOGY 173(1):10-20 Chung LWK; Baseman A; Assikis V; Zhau HE Molecular insights into prostate cancer progression: The missing link of tumor microenvironment | 0 | 0 |
| 50 | 2 | 71 | 122 2004 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS 4(5):599-607 Bustin SA; Dorudi S Gene expression profiling for molecular staging and prognosis prediction in colorectal cancer | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 1 | 70 | 56 2003 TRENDS IN GENETICS 19(10):570-577 Moreau Y; Aerts S; De Moor B; De Strooper B; Dabrowski M Comparison and meta-analysis of microarray data: from the bench to the computer desk | 1 | 8 |
| 52 | 1 | 70 | 110 2004 COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING 7(1):1-9 Gerner C Screening for disease-markers and investigating drug effects by proteome profiling: Can it meet expectations? | 0 | 0 |
| 53 | 4 | 70 | 200 2004 TRENDS IN MOLECULAR MEDICINE 10(8):387-392 Fong S; Debs RJ; Desprez PY Id genes and proteins as promising targets in cancer therapy | 0 | 0 |
| 54 | 1 | 68 | 125 2004 GENES & DEVELOPMENT 18(1):99-115 Timmerman LA; Grego-Bessa J; Raya A; Bertran E; Perez-Pomares JM; et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation | 1 | 7 |
| 55 | 1 | 67 | 142 2004 JOURNAL OF BIOMEDICAL INFORMATICS 37(4):293-303 Kuo WP; Kim EY; Trimarchi J; Jenssen TK; Vinterbo SA; et al. A primer on gene expression and microarrays for machine learning researchers | 0 | 0 |
| 56 | 2 | 67 | 196 2004 SEMINARS IN ONCOLOGY 31(1):39-53 Kohn EC; Lu YL; Wang HW; Yu QH; Yu SX; et al. Molecular therapeutics: Promise and challenges | 0 | 1 |
| 57 | 1 | 66 | 55 2003 PROSTATE 57(4):298-308 Witte JS; Suarez BK; Thiel B; Lin J; Yu A; et al. Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci | 0 | 5 |
| 58 | 3 | 66 | 132 2004 HUMAN MOLECULAR GENETICS 13(13):1303-1313 Paris PL; Andaya A; Fridlyand J; Jain AN; Weinberg V; et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors | 0 | 1 |
| 59 | 2 | 65 | 61 2004 APPLICATIONS OF BIOINFORMATICS IN CANCER DETECTION 1020:92-100 Kawasaki ES Microarrays and the gene expression profile of a single cell | 0 | 0 |
| 60 | 1 | 65 | 137 2004 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 13(4):483-495 Goldsmith ZG; Dhanasekaran N The microrevolution: Applications and impacts of microarray technology on molecular biology and medicine (Review) | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 1 | 64 | 58 2004 AMERICAN JOURNAL OF PATHOLOGY 164(3):903-914 Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas | 0 | 4 |
| 62 | 2 | 64 | 80 2004 CANCER RESEARCH 64(6):1975-1986 Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer | 1 | 12 |
| 63 | 1 | 64 | 108 2004 CLINICAL CANCER RESEARCH 10(12):3980-3987 Lim YP; Wong CY; Ooi LL; Druker BJ; Epstein RJ Selective tyrosine hyperphosphorylation of cytoskeletal and stress proteins in primary human breast cancers: Implications for adjuvant use of kinase-inhibitory drugs | 0 | 0 |
| 64 | 1 | 62 | 69 2004 BREAST CANCER RESEARCH 6(2):93-101 Schedin P; Elias A Multistep tumorigenesis and the microenvironment | 0 | 2 |
| 65 | 1 | 61 | 20 2003 EMBO REPORTS 4(12):1127-1131 Argraves WS; Greene LM; Cooley MA; Gallagher WM Fibulins: physiological and disease perspectives | 0 | 2 |
| 66 | 2 | 61 | 190 2004 PHARMACOGENOMICS JOURNAL 4(3):193-207 Debey S; Schoenbeck U; Hellmich M; Gathof BS; Pillai R; et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types | 1 | 2 |
| 67 | 2 | 60 | 82 2004 CANCER RESEARCH 64(8):2805-2816 Stein WD; Litman T; Fojo T; Bates SE Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: Comparing solid tumors with cell lines and comparing solid tumors from different tissue origins | 0 | 3 |
| 68 | 4 | 60 | 189 2004 PHARMACOGENOMICS 5(8):1117-1128 Liu ET Expression genomics and cancer biology | 0 | 0 |
| 69 | 2 | 59 | 90 2004 CANCER RESEARCH 64(23):8585-8594 Wang WG; Goswami S; Lapidus K; Wells AL; Wyckoff JB; et al. Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors | 0 | 0 |
| 70 | 1 | 59 | 117 2004 ENVIRONMENTAL HEALTH PERSPECTIVES 112(12):1236-1248 Steiner G; Suter L; Boess F; Gasser R; de Vera MC; et al. Discriminating different classes of toxicants by transcript profiling | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 1 | 59 | 145 2004 JOURNAL OF CELL BIOLOGY 167(4):769-781 Sabeh F; Ota I; Holmbeck K; Birkedal-Hansen H; Soloway P; et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP | 0 | 0 |
| 72 | 1 | 58 | 166 2004 MOLECULAR AND CELLULAR BIOLOGY 24(19):8662-8670 Astrof S; Crowley D; George EL; Fukuda T; Sekiguchi K; et al. Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis | 0 | 0 |
| 73 | 2 | 57 | 160 2004 JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY 25(4-5):303-308 Suyama E; Kawasaki H; Wadhwa R; Tajra K Cell migration and metastasis as targets of small RNA-based molecular genetic analyses | 0 | 0 |
| 74 | 2 | 56 | 10 2003 CANCER LETTERS 200(2):97-105 Hunter KW Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination | 1 | 3 |
| 75 | 1 | 53 | 96 2004 CARCINOGENESIS 25(12):2293-2301 Gu B; Espana L; Mendez O; Torregrosa A; Sierra A Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus | 0 | 0 |
| 76 | 3 | 53 | 175 2004 NATURE REVIEWS CANCER 4(6):448-456 Pantel K; Brakenhoff RH Dissecting the metastatic cascade | 1 | 4 |
| 77 | 2 | 52 | 100 2004 CELL CYCLE 3(6):718-721 Grego-Bessa J; Diez J; Timmerman L; de la Pompa JL Notch and epithelial-mesenchyme transition in development and tumor progression - Another turn of the screw | 0 | 0 |
| 78 | 1 | 52 | 114 2004 CURRENT OPINION IN MOLECULAR THERAPEUTICS 6(6):593-599 Sultmann H; Poustka A Recent advances in transcription profiling of human cancer | 0 | 0 |
| 79 | 1 | 51 | 35 2003 JOURNAL OF IMMUNOLOGY 171(8):4164-4174 Liu KB; McDuffie E; Abrams SI Exposure of human primary colon carcinoma cells to anti-Fas interaction influences the emergence of pre-existing Fas-resistant metastatic subpopulations | 0 | 1 |
| 80 | 1 | 51 | 126 2004 GENOME BIOLOGY 5(5) Grigoryev DN; Ma SF; Irizarry RA; Ye SQ; Quackenbush J; et al. Orthologous gene-expression profiling in multi-species models: search for candidate genes | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 1 | 50 | 7 2003 CANCER CELL 3(6):537-549 Kang YB; Siegel PM; Shu WP; Drobnjak M; Kakonen SM; et al. A multigenic program mediating breast cancer metastasis to bone | 21 | 66 |
| 82 | 1 | 50 | 171 2004 NATURE GENETICS 36(2):197-204 McCarroll SA; Murphy CT; Zou SG; Pletcher SD; Chin CS; et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging | 0 | 13 |
| 83 | 2 | 49 | 155 2004 JOURNAL OF HEPATOLOGY 41(2):284-291 Kurokawa Y; Matoba R; Takemasa I; Nagano H; Dono K; et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma | 1 | 4 |
| 84 | 1 | 49 | 192 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(25):9309-9314 Rhodes DR; Yu JJ; Shanker K; Deshpande N; Varambally R; et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression | 1 | 6 |
| 85 | 1 | 48 | 89 2004 CANCER RESEARCH 64(21):7813-7821 Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; et al. Profiling the evolution of human metastatic bladder cancer | 0 | 0 |
| 86 | 1 | 48 | 152 2004 JOURNAL OF CLINICAL ONCOLOGY 22(23):4648-4658 Spentzos D; Levine DA; Ramoni MF; Joseph M; Gu XS; et al. Gene expression signature with independent prognostic significance in epithelial ovarian cancer | 0 | 1 |
| 87 | 1 | 48 | 208 2005 JOURNAL OF ORAL PATHOLOGY & MEDICINE 34(2):77-86 Vigneswaran N; Wu J; Sacks P; Gilcrease M; Zacharias W Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma: possible insights from emerging technology | 0 | 0 |
| 88 | 2 | 47 | 21 2003 EXPERIMENTAL AND MOLECULAR MEDICINE 35(6):556-564 Kang KR; Chung SI Protein kinase CK2 phosphorylates and interacts wit deoxyhypusine synthase in HeLa cells | 0 | 0 |
| 89 | 1 | 47 | 34 2003 JOURNAL OF HEPATOLOGY 39(6):1004-1012 Kurokawa Y; Matoba R; Takemasa I; Nakamori S; Tsujie M; et al. Molecular features of non-B, non-C hepatocellular carcinoma: a PCR-array gene expression profiling study | 1 | 2 |
| 90 | 1 | 47 | 95 2004 CARCINOGENESIS 25(9):1599-1609 McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; et al. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 1 | 47 | 112 2004 COMPARATIVE AND FUNCTIONAL GENOMICS 5(1):39-47 Khan HA ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression data | 1 | 1 |
| 92 | 1 | 46 | 25 2003 FEBS LETTERS 546(1):98-102 Detours V; Dumont JE; Bersini H; Maenhaut C Integration and cross-validation of high-throughput gene expression data: comparing heterogeneous data sets | 1 | 7 |
| 93 | 1 | 46 | 131 2004 GYNECOLOGIC ONCOLOGY 95(3):437-448 Drew AF; Blick TJ; Lafleur MA; Tim ELM; Robbie MJ; et al. Correlation of tumor-and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice | 0 | 0 |
| 94 | 2 | 46 | 204 2005 CLINICAL CANCER RESEARCH 11(2):646-655 Sultmann H; von Heydebreck A; Huber W; Kuner R; Buness A; et al. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival | 0 | 0 |
| 95 | 1 | 45 | 78 2004 CANCER CELL 5(5):489-500 Chung CH; Parker JS; Karaca G; Wu JY; Funkhouser WK; et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression | 0 | 3 |
| 96 | 1 | 45 | 92 2004 CANCER RESEARCH 64(24):9209-9216 Shah RB; Mehra R; Chinnaiyan AM; Shen RL; Ghosh D; et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: Lessons from a rapid autopsy program | 0 | 0 |
| 97 | 1 | 45 | 170 2004 NATURE CELL BIOLOGY 6(6):507-514 Eustace BK; Sakurai T; Stewart JK; Yimlamai D; Unger C; et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness | 1 | 5 |
| 98 | 1 | 45 | 173 2004 NATURE MEDICINE 10(2):175-181 Yu YL; Khan J; Khanna C; Helman L; Meltzer PS; et al. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators | 1 | 16 |
| 99 | 1 | 45 | 178 2004 NEW ENGLAND JOURNAL OF MEDICINE 350(16):1605-1616 Bullinger L; Dohner K; Bair E; Frohling S; Schlenk RF; et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia | 2 | 30 |
| 100 | 1 | 45 | 212 2005 PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS 348:349-370 Blasi MF; Casorelli I; Colosimo A; Blasi FS; Bignami M; et al. A recursive network approach can identify constitutive regulatory circuits in gene expression data | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 2 | 44 | 93 2004 CANCER SCIENCE 95(3):197-204 Yokota J; Kohno T Molecular footprints of human lung cancer progression | 0 | 1 |
| 102 | 2 | 44 | 109 2004 CLINICAL CANCER RESEARCH 10(18):6029-6038 Kurokawa Y; Matoba R; Nagano H; Sakon M; Takemasa I; et al. Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma | 0 | 0 |
| 103 | 1 | 44 | 139 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(5):1279-1288 De Angelis PM; Fjell B; Kravik KL; Haug T; Tunheim SH; et al. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil | 0 | 1 |
| 104 | 1 | 44 | 148 2004 JOURNAL OF CLINICAL ONCOLOGY 22(5):811-819 Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction | 1 | 1 |
| 105 | 1 | 44 | 159 2004 JOURNAL OF MOLECULAR ENDOCRINOLOGY 33(3):663-677 Boelaert K; Yu R; Tannahill LA; Stratford AL; Khanim FL; et al. PTTG's C-terminal PXXP motifs modulate critical cellular processes in vitro | 0 | 0 |
| 106 | 1 | 43 | 184 2004 ONCOGENE 23(40):6830-6844 Jinawath N; Furukawa Y; Hasegawa S; Li MH; Tsunoda T; et al. Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray | 0 | 0 |
| 107 | 1 | 42 | 30 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(35):32683-32691 Park JH; Wolff EC; Folk JE; Park MH Reversal of the deoxyhypusine synthesis reaction - Generation of spermidine or homospermidine from deoxyhypusine by deoxyhypusine synthase | 1 | 5 |
| 108 | 1 | 42 | 191 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(3):811-816 Lapointe J; Li C; Higgins JP; van de Rijn M; Bair E; et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer | 2 | 14 |
| 109 | 1 | 41 | 18 2003 DRUG DISCOVERY TODAY 8(8):356-363 Huang Y; Sadee W Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach | 1 | 7 |
| 110 | 2 | 41 | 60 2004 ANNALS OF SURGICAL ONCOLOGY 11(8):727-730 Kappas AM; Fatouros M; Roukos DH Is it time to change surgical strategy for gastric cancer in the United States? | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 3 | 41 | 66 2004 BMC CANCER 4 Sloan KE; Eustace BK; Stewart JK; Zehetmeier C; Torella C; et al. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration | 0 | 0 |
| 112 | 2 | 41 | 94 2004 CARCINOGENESIS 25(7):1157-1163 Cuezva JM; Chen G; Isidoro A; Misek DE; Hanash SM; et al. The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis | 0 | 0 |
| 113 | 1 | 41 | 128 2004 GENOME BIOLOGY 5(8) Trainer AH Molecular tumor profiling: translating genomic insights into clinical advances | 0 | 0 |
| 114 | 1 | 41 | 156 2004 JOURNAL OF HEPATOLOGY 41(3):399-406 Utsunomiya T; Okamoto M; Hashimoto M; Yoshinaga K; Shiraishi T; et al. A gene-expression signature can quantify the degree of hepatic fibrosis in the rat | 0 | 1 |
| 115 | 1 | 39 | 130 2004 GYNECOLOGIC ONCOLOGY 92(2):559-567 Torng PL; Mao TL; Chan WY; Huang SC; Lin CT Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression | 0 | 1 |
| 116 | 1 | 38 | 3 2003 BMC BIOINFORMATICS 4 Culhane AC; Perriere G; Higgins DG Cross-platform comparison and visualisation of gene expression data using co-inertia analysis | 0 | 1 |
| 117 | 2 | 38 | 86 2004 CANCER RESEARCH 64(17):5973-5981 Qiu TH; Chandramouli GVR; Hunter KW; Alkharouf NW; Green JE; et al. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: Correlation to human disease | 1 | 2 |
| 118 | 2 | 37 | 85 2004 CANCER RESEARCH 64(11):3907-3913 Jain SJ; Watson MA; DeBenedetti MK; Hiraki Y; Moley JF; et al. Expression profiles provide insights into early malignant potential and skeletal abnormalities in multiple endocrine neoplasia type 2B syndrome tumors | 0 | 4 |
| 119 | 1 | 37 | 91 2004 CANCER RESEARCH 64(24):8846-8853 Planaguma J; Diaz-Fuertes M; Gil-Moreno A; Abal M; Monge M; et al. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma | 0 | 0 |
| 120 | 2 | 37 | 143 2004 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 130(8):460-468 Li Y; Tian B; Yang J; Zhao L; Wu X; et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 1 | 37 | 181 2004 ONCOGENE 23(31):5360-5370 Tomida S; Koshikawa K; Yatabe Y; Harano T; Ogura N; et al. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 0 | 0 |
| 122 | 2 | 37 | 183 2004 ONCOGENE 23(39):6684-6692 Reis EM; Nakaya HI; Louro R; Canavez FC; Flatschart AVF; et al. Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer | 0 | 0 |
| 123 | 1 | 36 | 70 2004 BRITISH JOURNAL OF CANCER 90(3):686-692 Adib TR; Henderson S; Perrett C; Hewitt D; Bourmpoulia D; et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays | 0 | 3 |
| 124 | 1 | 36 | 84 2004 CANCER RESEARCH 64(9):3037-3045 Jones C; Mackay A; Grigoriadis A; Cossu A; Reis-Filho JS; et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: Identification of novel prognostic markers for breast cancer | 0 | 4 |
| 125 | 2 | 36 | 97 2004 CELL 117(7):927-939 Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis | 1 | 13 |
| 126 | 1 | 36 | 163 2004 LEUKEMIA 18(3):556-565 Choi YL; Makishima H; Ohashi J; Yamashita Y; Ohki R; et al. DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3(-)CD56(+) fractions | 0 | 1 |
| 127 | 1 | 36 | 185 2004 ONCOGENE 23(55):8997-9006 Ohali A; Avigad S; Zaizov R; Ophir R; Horn-Saban S; et al. Prediction of high risk Ewing's sarcoma by gene expression profiling | 0 | 0 |
| 128 | 1 | 36 | 194 2004 PROTEOMICS 4(9):2776-2788 Seike M; Kondo T; Fujii K; Yamada T; Gemma A; et al. Proteomic signature of human cancer cells | 0 | 0 |
| 129 | 1 | 36 | 211 2005 NATURE GENETICS 37(1):48-55 Sweet-Cordero A; Mukherjee S; Subramanian A; You H; Roix JJ; et al. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis | 0 | 1 |
| 130 | 3 | 35 | 71 2004 BRITISH JOURNAL OF CANCER 90(4):752-755 Hunter KW Host genetics and tumour metastasis | 2 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 1 | 35 | 149 2004 JOURNAL OF CLINICAL ONCOLOGY 22(13):2671-2680 Takeuchi H; Morton DL; Kuo C; Turner RR; Elashoff D; et al. Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients | 0 | 1 |
| 132 | 1 | 34 | 123 2004 FEBS LETTERS 556(1-3):221-226 Lener T; Burgstaller G; Gimona M The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats | 0 | 1 |
| 133 | 3 | 34 | 168 2004 MOLECULAR CANCER RESEARCH 2(10):551-556 Pinkas J; Martin SS; Leder P Bcl-2-mediated cell survival promotes metastasis of EpH4 beta MEKDD mammary epithelial cells | 0 | 0 |
| 134 | 3 | 34 | 205 2005 GENES CHROMOSOMES & CANCER 42(3):299-307 Kohlmann A; Schoch C; Dugas M; Rauhut S; Weninger F; et al. Pattern robustness of diagnostic gene expression signatures in leukemia | 0 | 0 |
| 135 | 1 | 33 | 33 2003 JOURNAL OF EXPERIMENTAL MEDICINE 198(11):1753-1757 Dhodapkar MV; Krasovsky J; Osman K; Geller MD Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy | 0 | 4 |
| 136 | 1 | 33 | 164 2004 LUNG CANCER 45:S145-S150 Muller-Tidow C; Diederichs S; Thomas M; Serve H Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer | 0 | 0 |
| 137 | 1 | 33 | 177 2004 NEOPLASIA 6(6):744-750 Pilarsky C; Wenzig M; Specht T; Saeger HD; Grutzmann R Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data | 0 | 0 |
| 138 | 1 | 32 | 28 2003 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 84(4):173-183 Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; et al. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer | 0 | 0 |
| 139 | 1 | 32 | 41 2003 LUNG CANCER 41:S3-S8 Johnson DH Targeted therapy in non-small cell lung cancer: myth or reality | 0 | 1 |
| 140 | 1 | 32 | 134 2004 INTERNATIONAL JOURNAL OF CANCER 108(3):412-417 Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients | 1 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 1 | 32 | 202 2005 BIOINFORMATICS 21(2):171-178 Ein-Dor L; Kela I; Getz G; Givol D; Domany E Outcome signature genes in breast cancer: is there a unique set? | 0 | 0 |
| 142 | 2 | 32 | 207 2005 JOURNAL OF MOLECULAR BIOLOGY 345(4):645-649 Khan HA ArrayVigil: A methodology for statistical comparison of gene signatures using segregated-one-tai led (SOT) Wilcoxon's signed-rank test | 0 | 0 |
| 143 | 1 | 31 | 43 2003 MOLECULAR CANCER RESEARCH 1(5):362-375 Porter D; Lahti-Domenici J; Keshaviah A; Bae YK; Argani P; et al. Molecular markers in ductal carcinoma in situ of the breast | 3 | 28 |
| 144 | 1 | 31 | 72 2004 BRITISH JOURNAL OF CANCER 90(5):1041-1046 Savinainen KJ; Linja MJ; Saramaki OR; Tammela TLJ; Chang GTG; et al. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer | 0 | 1 |
| 145 | 1 | 30 | 147 2004 JOURNAL OF CLINICAL INVESTIGATION 113(6):913-923 Glinsky GV; Glinskii AB; Stephenson AJ; Hoffman RM; Gerald WL Gene expression profiling predicts clinical outcome of prostate cancer | 0 | 4 |
| 146 | 4 | 30 | 172 2004 NATURE GENETICS 36(10):1090-1098 Segal E; Friedman N; Koller D; Regev A A module map showing conditional activity of expression modules in cancer | 0 | 0 |
| 147 | 0 | 29 | 45 2003 NATURE GENETICS 33(1):49-54 Ramaswamy S; Ross KN; Lander ES; Golub TR A molecular signature of metastasis in primary solid tumors | 211 | 211 |
| 148 | 1 | 29 | 157 2004 JOURNAL OF IMMUNOLOGY 172(11):7103-7109 Feezor RJ; Baker HV; Xiao WH; Lee WA; Huber TS; et al. Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair | 0 | 0 |
| 149 | 1 | 29 | 197 2004 SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND 2(1):1-6 Thompson AM Dissecting the molecular mechanisms of human cancer: Translating laboratory advances into clinical practice | 0 | 0 |
| 150 | 1 | 28 | 11 2003 CANCER RESEARCH 63(16):4781-4785 Lieberfarb ME; Lin M; Lechpammer M; Li C; Tanenbaum DM; et al. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP | 1 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 5 | 28 | 68 2004 BREAST CANCER RESEARCH 6(2):61-64 Welch DR Microarrays bring new insights into understanding of breast cancer metastasis to bone | 1 | 2 |
| 152 | 2 | 28 | 199 2004 SURGERY 136(3):511-518 Matros E; Wang ZGC; Richardson AL; Iglehart JD Genomic approaches in cancer biology | 0 | 0 |
| 153 | 1 | 28 | 203 2005 BLOOD 105(2):821-826 Cario G; Stanulla M; Fine BM; Teuffel O; Neuhoff NV; et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia | 0 | 0 |
| 154 | 2 | 27 | 54 2003 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 100(26):15901-15905 Weigelt B; Glas AM; Wessels LFA; Witteveen AT; Peterse JL; et al. Gene expression profiles of primary breast tumors maintained in distant metastases | 6 | 11 |
| 155 | 4 | 27 | 99 2004 CELL CYCLE 3(1):29-31 Klein CA Gene expression signatures, cancer cell evolution and metastatic progression | 0 | 1 |
| 156 | 1 | 27 | 146 2004 JOURNAL OF CHEMOMETRICS 18(3-4):125-132 Musumarra G; Barresi V; Condorelli DF; Fortuna CG; Scire S Potentialities of multivariate approaches in genome-based cancer research: identification of candidate genes for new diagnostics by PLS discriminant analysis | 0 | 0 |
| 157 | 1 | 27 | 174 2004 NATURE MEDICINE 10(2):182-186 Khanna C; Wan XL; Bose S; Cassaday R; Olomu O; et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis | 2 | 13 |
| 158 | 1 | 26 | 57 2004 AMERICAN JOURNAL OF PATHOLOGY 164(1):23-33 Rook MS; Delach SM; Deyneko G; Worlock A; Wolfe JL Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping | 0 | 3 |
| 159 | 1 | 26 | 59 2004 ANNALS OF SURGICAL ONCOLOGY 11(2):127-129 Roukos DH Early-stage gastric cancer: A highly treatable disease | 1 | 1 |
| 160 | 1 | 26 | 141 2004 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 291(22):2713-2719 Johansson JE; Andren O; Andersson SO; Dickman PW; Holmberg L; et al. Natural history of early, localized prostate cancer | 0 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 1 | 26 | 154 2004 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH 23(3):513-520 Hata F; Nishimori H; Yasoshima T; Tanaka H; Ohno K; et al. Profiling analysis of differential gene expression between hematogenous and peritoneal metastatic sublines of human pancreatic cancer using a DNA chip | 0 | 0 |
| 162 | 1 | 25 | 13 2003 CANCER RESEARCH 63(22):7785-7790 Yamamoto N; Yang M; Jiang P; Xu MX; Tsuchiya H; et al. Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging | 0 | 4 |
| 163 | 1 | 25 | 16 2003 CURRENT OPINION IN CELL BIOLOGY 15(5):640-644 Houshmand P; Zlotnik A Targeting tumor cells | 0 | 1 |
| 164 | 1 | 25 | 39 2003 JOURNAL OF UROLOGY 170(6):S11-S19 Febbo PG; Sellers WR Use of expression analysis to predict outcome after radical prostatectomy | 0 | 0 |
| 165 | 2 | 25 | 64 2004 BIOCHEMICAL JOURNAL 378:17-20 Isidoro A; Martinez M; Fernandez PL; Ortega AD; Santamaria G; et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer | 0 | 0 |
| 166 | 2 | 25 | 76 2004 BRITISH JOURNAL OF CANCER 91(6):1160-1165 De Smet F; Moreau Y; Engelen K; Timmerman D; Vergote I; et al. Balancing false positives and false negatives for the detection of differential expression in malignancies | 0 | 0 |
| 167 | 1 | 25 | 87 2004 CANCER RESEARCH 64(19):6973-6977 Brabletz T; Spaderna S; Kolb J; Hlubek F; Faller G; et al. Down-regulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: An active role for the tumor environment in malignant tumor progression | 0 | 0 |
| 168 | 1 | 24 | 67 2004 BRAIN PATHOLOGY 14(3):297-303 Watson MA; Perry A; Tihan T; Prayson RA; Guha A; et al. Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors | 0 | 0 |
| 169 | 1 | 24 | 73 2004 BRITISH JOURNAL OF CANCER 90(8):1577-1582 Dawson LA; Maitland NJ; Turner AJ; Usmani BA Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression | 0 | 0 |
| 170 | 1 | 24 | 186 2004 ONCOLOGY REPORTS 11(3):677-680 Bauer M; Aust G; Schumacher U Different transcriptional expression of KIAA1324 and its splicing variants in human carcinoma cell lines with different metastatic capacity | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 1 | 23 | 5 2003 CANCER 98(8):1569-1577 Foulkes WD; Metcalfe K; Hanna W; Lynch HT; Ghadirian P; et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma | 2 | 5 |
| 172 | 5 | 23 | 102 2004 CELL CYCLE 3(10):1250-1251 Malins DC Metastasizing and non-metastasizing tumors likely evolve from DNA phenotypes via independent pathways | 0 | 0 |
| 173 | 1 | 23 | 104 2004 CHEST 125(5):111S-115S Kaminski N; Krupsky M Gene expression patterns, prognostic and diagnostic markers, and lung cancer biology | 0 | 0 |
| 174 | 2 | 23 | 201 2005 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 326(2):268-273 Chan BCL; Li Q; Chow SKY; Ching AKK; Liew CT; et al. BRE enhances in vivo growth of tumor cells | 0 | 0 |
| 175 | 1 | 22 | 19 2003 DRUG NEWS & PERSPECTIVES 16(4):217-221 Gant TW Application of toxicogenomics in drug development | 0 | 3 |
| 176 | 2 | 22 | 105 2004 CLINICAL CANCER RESEARCH 10(9):3104-3109 Mehrotra J; Vali M; McVeigh M; Kominsky SL; Fackler MJ; et al. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung | 0 | 1 |
| 177 | 1 | 22 | 106 2004 CLINICAL CANCER RESEARCH 10(10):3422-3428 Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; et al. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells | 1 | 1 |
| 178 | 2 | 22 | 107 2004 CLINICAL CANCER RESEARCH 10(10):3457-3464 Gangnus R; Langer S; Breit E; Pantel K; Speicher MR Genomic profiling of viable and proliferative micrometastatic cells from early-stage breast cancer patients | 1 | 1 |
| 179 | 1 | 22 | 138 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(2):305-312 Li MH; Lin YM; Hasegawa S; Shimokawa T; Murata K; et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray | 0 | 1 |
| 180 | 3 | 22 | 150 2004 JOURNAL OF CLINICAL ONCOLOGY 22(16):3209-3211 Dubinett SM; Elashoff D; Meyerson M Assessing prognosis in non-small-cell lung cancer: Avenues to a more complete picture? | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 181 | 1 | 22 | 162 2004 LANCET 363(9411):775-781 Jones MH; Virtanen C; Honjoh D; Miyoshi T; Satoh Y; et al. Two prognostically significant subtypes of high-grade lung neuroendocrine turnours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles | 0 | 4 |
| 182 | 1 | 22 | 182 2004 ONCOGENE 23(31):5371-5377 Erez A; Perelman M; Hewitt SM; Cojacaru G; Goldberg I; et al. Sil overexpression in lung cancer characterizes tumors with increased mitotic activity | 0 | 1 |
| 183 | 2 | 22 | 193 2004 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 101(31):11428-11431 Malins DC; Gilman NK; Green VM; Wheeler TM; Barker EA; et al. Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomas | 1 | 1 |
| 184 | 1 | 21 | 12 2003 CANCER RESEARCH 63(18):5669-5673 Collisson EA; De A; Suzuki H; Gambhir SS; Kolodney MS Treatment of metastatic melanoma with an orally available inhibitor of the Ras-Raf-MAPK cascade | 0 | 8 |
| 185 | 1 | 21 | 62 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 320(4):1328-1336 Ohki-Kaneda R; Ohashi J; Yamamoto K; Ueno S; Ota J; et al. Cardiac function-related gene expression profiles in human atrial myocytes | 0 | 0 |
| 186 | 2 | 21 | 63 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325(3):784-791 Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; et al. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations | 0 | 0 |
| 187 | 1 | 21 | 133 2004 INTERNATIONAL IMMUNOPHARMACOLOGY 4(14):1829-1836 Motomura K; Toyoda N; Oishi K; Sato H; Nagai S; et al. Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals | 0 | 0 |
| 188 | 1 | 21 | 135 2004 INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY 48(5-6):457-462 Hart IR; Fidler IJ From here to there; a life based on migration - An interview with Isaiah J. Fidler | 0 | 0 |
| 189 | 1 | 20 | 74 2004 BRITISH JOURNAL OF CANCER 90(10):1976-1982 Patmore HS; James NEA; Cawkwell L; MacDonald A; Stafford ND; et al. Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? | 0 | 1 |
| 190 | 1 | 20 | 81 2004 CANCER RESEARCH 64(7):2469-2473 Bockhorn M; Roberge S; Sousa C; Jain RK; Munn LL Differential gene expression in metastasizing cells shed from kidney tumors | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 191 | 1 | 20 | 83 2004 CANCER RESEARCH 64(9):2962-2968 Yu K; Lee CH; Tan PH; Hong GS; Wee SB; et al. A molecular signature of the Nottingham prognostic index in breast cancer | 0 | 1 |
| 192 | 2 | 20 | 88 2004 CANCER RESEARCH 64(20):7201-7204 Lee YF; John M; Falconer A; Edwards S; Clark J; et al. A gene expression signature associated with metastatic outcome in human leiomyosarcomas | 0 | 0 |
| 193 | 1 | 20 | 140 2004 INTERNATIONAL JOURNAL OF ONCOLOGY 24(6):1589-1596 Lahdesmaki H; Hao XS; Sun BC; Hu LM; Yli-Harja O; et al. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis | 0 | 0 |
| 194 | 1 | 20 | 198 2004 SURGERY 136(3):500-503 Eschrich S; Yeatman TJ DNA microarrays and data analysis: An overview | 0 | 0 |
| 195 | 3 | 19 | 14 2003 CELL 113(7):821-823 Hynes RO Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants - or both? | 5 | 11 |
| 196 | 3 | 19 | 77 2004 BULLETIN DU CANCER 91(2):129-132 Raguenez G; Blanc E; Benard J Metastatic potential: a generic characteristic of the primary tumor | 0 | 0 |
| 197 | 3 | 19 | 98 2004 CELL 118(3):277-279 Kang YB; Massague J Epithelial-mesenchymal transitions: Twist in development and metastasis | 0 | 1 |
| 198 | 2 | 18 | 101 2004 CELL CYCLE 3(6):756-757 Weigelt B; van't Veer LJ Hard-wired genotype in metastatic breast cancer | 0 | 0 |
| 199 | 3 | 18 | 206 2005 JOURNAL OF CLINICAL INVESTIGATION 115(1):44-55 Minn AJ; Kang YB; Serganova I; Gupta GP; Giri DD; et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors | 0 | 0 |
| 200 | 1 | 17 | 127 2004 GENOME BIOLOGY 5(6) Grose R Common ground in the transcriptional profiles of wounds and tumors | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 201 | 1 | 17 | 210 2005 LANCET 365(9458):488-492 Michiels S; Koscielny S; Hill C Prediction of cancer outcome with microarrays: a multiple random validation strategy | 0 | 0 |
| 202 | 1 | 16 | 65 2004 BMC BIOINFORMATICS 5 Jiang HY; Deng YP; Chen HS; Tao L; Sha QY; et al. Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes | 0 | 1 |
| 203 | 1 | 15 | 188 2004 PHARMACOGENOMICS 5(3):233-237 Stallings SC Who'll be first? Genomic biomarkers impact on drug discovery and clinical practice | 0 | 0 |
| 204 | 1 | 14 | 40 2003 LANCET 361(9369):1576-1577 Ramaswamy S; Perou CM DNA microarrays in breast cancer: the promise of personalised medicine | 1 | 7 |
| 205 | 1 | 13 | 6 2003 CANCER 98(12):2687-2692 Fuchs B; Valenzuela RG; Inwards C; Sim FH; Rock MG Complications in long-term survivors of Ewing sarcoma | 0 | 4 |
| 206 | 1 | 9 | 46 2003 NATURE GENETICS 34(1):23-24 Hunter K; Welch DR; Liu ET Genetic background is an important determinant of metastatic potential | 6 | 9 |
| 207 | 2 | 7 | 42 2003 M S-MEDECINE SCIENCES 19(11):1050-1051 Raguenez G; Benard J Molecular signature for cancer metastasis | 0 | 0 |
| 208 | 1 | 5 | 44 2003 NATURE GENETICS 33(1):10-11 Liotta LA; Kohn EC Cancer's deadly signature | 9 | 12 |
| 209 | 1 | 5 | 75 2004 BRITISH JOURNAL OF CANCER 91(4):813-813 Iizuka N; Oka M CIITA methylation and decreased levels of HLA-DR in tumour progression | 0 | 0 |
| 210 | 1 | 2 | 48 2003 NATURE REVIEWS CANCER 3(1):4-5 Novak K Stay or go? | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 211 | 1 | 2 | 51 2003 NATURE REVIEWS GENETICS 4(2):84-84 Baxter C Molecular signatures | 0 | 0 |
| 212 | 2 | 2 | 161 2004 LABORATORY INVESTIGATION 84(4):395-396 Xu RL; Jaffer S Is metastatic potential of breast cancer inherent or acquired? | 0 | 0 |
Generated by: HistCite 2004.12.21